ASH 2024 Summary: Highlights in Bone Marrow Failure Disorders

2024 ASH Annual Meeting Insights Hub

P. Scheinberg

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Switching ITP Patients to Avatrombopag From Other TPO-RAs: When to D…

Keck School of Medicine of USC

H. Liebman

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Natural History of ITP: Navigating the Journey

Platelet Disorder Support Association (PDSA)

D. Kuter

Management of iTTP

Yazan Abou-Ismail

Evolving Treatment Landscape in ITP

Robert Bird

2024 Benign Hematology Updates

University of Colorado Division of Hematology

L. Chu

Clots in the Visceral and Cerebral Veins: Evidence, Guidelines and T…

Marc Zumberg

ITP: Diagnosis, Pathophysiology, and Management Guidelines

Songphol Tungjitviboonkun

Causes of Secondary ITP and Long-Term Risk of Other Diseases in ITP …

Platelet Disorder Support Association (PDSA)

D. Kuter

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Updates on the Evolving Treatment Landscape for ITP

Cindy Neunert

Where Does Rituximab Fit in ITP

Platelet Disorder Support Association (PDSA)

D. Nugent

ITP and Aging: Addressing the Unique Challenges

Platelet Disorder Support Association (PDSA)

C. Kessler

Preventing Relapse in iTTP

Senthil Sukumar